Press release - 14/02/2008 Space sickness - learning from fish Gravitation biologist Dr. Ralf Anken of the University of Hohenheim talks about his research with fish in an interview with Sandra Leppin from Hohenheim University. Anken At zero gravity the impressions received by the eyes and the organs of equilibrium do not coincide.https:////www.gesundheitsindustrie-bw.de/en/article/press-release/space-sickness-learning-from-fish
Article - 12/02/2008 Hermann Bujard - a passionate basic researcher As one of the people who initiated the establishment of EMBL and in his role as founding director of the ZMBH Hermann Bujard has made a considerable contribution to the transformation of Heidelberg into a leading location for molecular and biological research in Germany. As the director of EMBO Bujard is now promoting the development of molecular biosciences across Europe.https:////www.gesundheitsindustrie-bw.de/en/article/news/hermann-bujard-a-passionate-basic-researcher
Press release - 11/02/2008 BPI opens office in Brussels The new BPI office in Brussels will represent the European interests of German location-oriented pharmaceutical companies at European institutions. It is headed by Dr. Alexander Natz a lawyer who previously worked for the Sträter law firm in Bonn.https:////www.gesundheitsindustrie-bw.de/en/article/press-release/bpi-opens-office-in-brussels
Press release - 11/02/2008 Priority programme "Membrane envelope of virus particles and cellular structures" Applications written in English must be submitted to DFG by 31st March 2008.https:////www.gesundheitsindustrie-bw.de/en/article/press-release/priority-programme-membrane-envelope-of-virus-particles-and-cellular-structures
Article - 11/02/2008 Human clones and reprogrammed skin cell In 1998 James Thomson was the first to generate stem cells from human embryos. BIOPRO will present the new methods in the field of embryonic stem cell research. Stem cell experts regeneration biologists medics and ethicists will explain whether they think that the new methods are useful or not.https:////www.gesundheitsindustrie-bw.de/en/article/news/human-clones-and-reprogrammed-skin-cell
Article - 11/02/2008 One-Stop-Service for SMEs European Commission Vice President Günter Verheugen launched Enterprise Europe Network a new and powerful European support network for enterprises. All major players of the business support community in Europe have united to offer a one-stop service to assist especially small and medium sized enterprises.https:////www.gesundheitsindustrie-bw.de/en/article/news/one-stop-service-for-smes
Article - 11/02/2008 Reinhart Koselleck Projects A new funding module from the German Research Foundation provides funding to the tune of up to 1.25 million euros.https:////www.gesundheitsindustrie-bw.de/en/article/news/reinhart-koselleck-projects
Article - 10/02/2008 The only professorship for preclinical imaging in Europe is in Tübingen The University of Tübingen opened its new laboratory for Preclinical Imaging and Imaging Technology of the Werner Siemens Foundation. The professorship is the only one in Europe combining preclinical imaging and the development of new imaging technologies.https:////www.gesundheitsindustrie-bw.de/en/article/news/the-only-professorship-for-preclinical-imaging-in-europe-is-in-tuebingen
Press release - 10/02/2008 First Baden-Württemberg university approved for embryonic stem cell research The biochemist Prof. Marcel Leist from Constance is the first Baden-Württemberg scientist to be authorised to undertake research using embryonic stem cells. Leist is investigating the effect of drugs and chemicals on human nerve cells.https:////www.gesundheitsindustrie-bw.de/en/article/press-release/first-baden-wuerttemberg-university-approved-for-embryonic-stem-cell-research
Article - 10/02/2008 4th Biomarker Workshop at the NMI in Reutlingen: another success The Biomarker Workshop held at the NMI in late January has become a fixed date for a growing number of proteomics researchers. With an attendance of 130 this years workshop exceeded all previous ones. Those who were keen to find out more about the latest trends and findings were presented with a successful mix of basic and applied research information.https:////www.gesundheitsindustrie-bw.de/en/article/news/4th-biomarker-workshop-at-the-nmi-in-reutlingen-another-success
Press release - 10/02/2008 Nycomed’s Ciclesonide to be commercialised in the United States by Sepracor Nycomed has granted Sepracor Inc. NASDAQ SEPR the exclusive development marketing and commercialisation rights for Ciclesonide in the United States. Ciclesonide is Nycomeds patented corticosteroid with a novel principle of action.https:////www.gesundheitsindustrie-bw.de/en/article/press-release/nycomed-s-ciclesonide-to-be-commercialised-in-the-united-states-by-sepracor
Press release - 09/02/2008 Pharma and life sciences industry as growth sector The CEOs of pharmaceutical and life science companies are becoming increasingly aware that their companies are facing growing challenges and risks at the global level. At the same time they are also aware of more and more opportunities. https:////www.gesundheitsindustrie-bw.de/en/article/press-release/pharma-and-life-sciences-industry-as-growth-sector
Article - 09/02/2008 A better alternative from the perspective of embryo protection Karin Bundschuh of BIOPRO Baden-Württemberg asked Dr. Jens Clausen how these developments should be viewed from an ethical perspective. The bioethicist spent many years studying the status of embryos the ethics of cloning and stem cell research.https:////www.gesundheitsindustrie-bw.de/en/article/news/a-better-alternative-from-the-perspective-of-embryo-protection
Article - 08/02/2008 New specialist outpatient clinic offers help for people suffering from haemochromatosis A new specialist outpatient clinic at the University Hospital of Ulm is treating haemochromatosis sufferers and is investigating the causes of this disease. Haemochromatosis which as the effect of poisoning the body is one of the most frequent hereditary diseases.https:////www.gesundheitsindustrie-bw.de/en/article/news/new-specialist-outpatient-clinic-offers-help-for-people-suffering-from-haemochromatosis
Article - 08/02/2008 Nycomed and Wyeth announce launch of an own generic version of PROTONIX® – lawsuit to defend patent continues Nycomed and its licence holder Wyeth Pharmaceuticals a division of Wyeth NYSEWYE today announced the U.S. launch of an own generic version of PROTONIX Pantoprazole tablets in response to the at-risk launch of generic Pantoprazole tablets by Teva Pharmaceuticals USA Inc.https:////www.gesundheitsindustrie-bw.de/en/article/press-release/nycomed-and-wyeth-announce-launch-of-an-own-generic-version-of-protonix-lawsuit-to-defend-patent-con
Press release - 07/02/2008 Bridging the gap between preclinical and clinical training The Theatrum Anatomicum enriches medical training at the University of Ulm. That is the unanimous verdict of the lecturers involved in medical training. The Theatrum is a fully equipped demonstration operation theatre with standing room for approximately 70 people.https:////www.gesundheitsindustrie-bw.de/en/article/press-release/bridging-the-gap-between-preclinical-and-clinical-training
Article - 07/02/2008 New life sciences centre in Ulm The new Life Science Centre will house eleven interfaculty research groups dealing with aspects of tissue regeneration. The state of Baden-Württemberg and the University both expressed their high expectations for the centre at the official opening.https:////www.gesundheitsindustrie-bw.de/en/article/news/new-life-sciences-centre-in-ulm
Press release - 06/02/2008 CSS-Systemhaus Schlegel: Plant cultures with an electronic identity card A software developed by the Stuttgart-based Systemhaus Schegel covers all activities related to administering cultures it guarantees the foolproof production and propagation of plants and when printed out on a thermal printer incorporates all the necessary information on a barcode label.https:////www.gesundheitsindustrie-bw.de/en/article/press-release/css-systemhaus-schlegel-plant-cultures-with-an-electronic-identity-card
Article - 06/02/2008 German Bundestag positive about new Genetic Engineering Law The German Bundestag gave the go ahead for the new version of the German Genetic Engineering Law. The new version incorporates the introduction of the Not genetically engineered label as well as stricter regulations on the cultivation of genetically modified plants.https:////www.gesundheitsindustrie-bw.de/en/article/news/german-bundestag-positive-about-new-genetic-engineering-law
Article - 05/02/2008 Protecting the liver from oxygen stress The Emmy Noether junior research group in the Department of Surgery at the University Hospital of Heidelberg is to be funded with 1.2 million over the next five years. The group will focus on how tissue damage in donor livers can be prevented. The group headed by Dr. Martin Schneider.https:////www.gesundheitsindustrie-bw.de/en/article/news/protecting-the-liver-from-oxygen-stress
Article - 03/02/2008 Reversal of R&D expenditure According to estimates by the German Federal Minister of Research and Education Annette Schavan Germany is on the right path towards the objective of spending three per cent of the countrys gross domestic product on research and development RD by the year 2010.https:////www.gesundheitsindustrie-bw.de/en/article/news/reversal-of-r-d-expenditure
Article - 02/02/2008 Mannheim: Excellence Centre of Dermatology The new University Clinic for Dermatology Venerology and Allergology building located on the Mannheim hospital campus has now been opened. The hospital directed by Prof. Dr. med. Sergij Goerdt treats approximately 2000 patients on an inpatient basis.https:////www.gesundheitsindustrie-bw.de/en/article/news/mannheim-excellence-centre-of-dermatology
Dossier - 01/02/2008 Glycobiotechnology - sugar research is picking up speed Alongside DNA and proteins sugar structures play an important role in cellular transport and communication processes. They are also part of the molecular control and regulation machinery making them of particular interest to biotechnologists. The pharmaceutical industry as well as the food sector and material sciences have realised the potential of sugar structures.https:////www.gesundheitsindustrie-bw.de/en/article/dossier/glycobiotechnology-sugar-research-is-picking-up-speed
Press release - 01/02/2008 Dr. Victor Sourjik receives C.H.S. Award 2007 Victor Sourjik received the prize for his research in the field of cellular signalling and as support for his research project on the analysis of bacterial chemotaxis. The award comes with a purse of 100000 which the beneficiary can use to carry out research projects. https:////www.gesundheitsindustrie-bw.de/en/article/press-release/dr-victor-sourjik-receives-c-h-s-award-2007
Press release - 01/02/2008 Venture capital: Life sciences/ biotechnology investments VC-facts has published the Life Sciences Venture Capital Yearbook for the first time 2007. It shows that the total volume of financing in the life sciences amounts to 438.65 million euros.https:////www.gesundheitsindustrie-bw.de/en/article/press-release/venture-capital-life-sciences-biotechnology-investments